Artificial Intelligence

Documents

FDA

Reference 29 - Acute lung injury following gadolinium contrast

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 30 - Comparison of Human Tissue Gadolinium Retention and Elimination between Gadoteridol and Gadobenate

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 31 - Gadolinium-based contrast agent-induced neurotoxicity seeing is believing

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 32 - Caught in the act Allergic-like reaction to

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 33 - Acute respiratory distress syndrome after the use of gadolinium contrast agent.

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 34 - Immediate Adverse Reactions to Gandolinium-Based MR Contrast Media

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 35 - The Impact of Gadolinium on Quantitative Myelin Metrics

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 36 - Effects of gadolinium

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 37 - Gadolinium Contrast Agent Deposition in Children

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 38 - Ultrastructural Evidence of Dermal Gadolinium Deposits

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 39 - Delineating toxicity mechanisms associated with MRI contrast

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 40 - The involvement of proinflammatory cytokines in nephrogenic systemic fibrosis

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →